Cushing's Syndrome clinical trials at UCSF
1 research study open to eligible people
Cushing's syndrome is a disorder where the body produces excess cortisol. UCSF is investigating the use of osilodrostat in young patients with Cushing's disease. The trial examines the drug's behavior in the body and its safety for children.
Showing trials for
(PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients with Cushing's Disease
open to eligible people ages 6-17
Multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent patients with Cushing's disease.
San Francisco, California and other locations
Last updated: